AYTU BIOPHARMA CEO Joshua Disbrow's 2018 pay falls 42% to $606K
AYTU BIOPHARMA reports 2018 executive compensation
By ExecPay News
Published: February 25, 2019
AYTU BIOPHARMA reported fiscal year 2018 executive compensation information on February 25, 2019.
In 2018, six executives at AYTU BIOPHARMA received on average a compensation package of $332K, a 62% decrease compared to previous year.
Average pay of disclosed executives at AYTU BIOPHARMA
Joshua R. Disbrow, Chief Executive Officer, received $606K in total, which decreased by 42% compared to 2017. 50% of Disbrow's compensation, or $303K, was in salary. Disbrow also received $303K in stock awards.
since December Jarrett T. Disbrow, Chief Operating Officer, received a compensation package of $452K, which decreased by 53% compared to previous year. 55% of the compensation package, or $250K, was in salary.
Jarrett T. Disbrow, Chief Operating Officer, earned $452K in 2018.
David A. Green, Chief Financial Officer, received $287K in 2018.
since December Gregory A. Gould, Chief Financial Officer, earned $96K in 2018, a 85% decrease compared to previous year.
Gregory A. Gould, Chief Financial Officer, received $96K in 2018.
AYTU BIOPHARMA's fiscal year ends on June 30.
Related executives
Joshua Disbrow
AYTU BIOPHARMA
Chief Executive Officer
since Disbrow
AYTU BIOPHARMA
Chief Operating Officer
David Green
AYTU BIOPHARMA
Chief Financial Officer
since Gould
AYTU BIOPHARMA
Chief Financial Officer
Jarrett Disbrow
AYTU BIOPHARMA
Chief Operating Officer
Gregory Gould
AYTU BIOPHARMA
Chief Financial Officer
You may also like
Source: SEC filing on February 25, 2019.